Maxillary osteonecrosis as a complication of COVID-19 (Clinical cases)
Year: 2024, volume 20 Issue: №4 Pages: 381-384
Heading: Stomatology Article type: Original article
Authors: Rogatina T.V., Erokina N.L., Lepilin A.V., Bakhteeva G.R., Savelyeva S.S.
Organization: Saratov State Medical University
Heading: Stomatology Article type: Original article
Authors: Rogatina T.V., Erokina N.L., Lepilin A.V., Bakhteeva G.R., Savelyeva S.S.
Organization: Saratov State Medical University
Summary:
The article describes cases of osteonecrosis of the Maxilla resulting from COVID-19. They demonstrate the characteristics of patients who experienced this complication and draw attention to treatment methods that were effective for this pathology. The authors concluded that complex therapy, including drugs whose action is aimed at normalizing microcirculation in tissues and increasing the body's resistance, contributed to the delimitation of areas of necrosis of the Maxilla and the successful outcome of surgical treatment.
Bibliography:
1. Belotserkovskaia YuG, Romanovskikh AG, Smirnov IP. COVID-19: A respiratory infection caused by new coronavirus: new data on epidemiology, clinical course, and patient management. Consilium Medicum. 2020; 22 (3): 12-20. DOI: 10.26442/20751753.20009
2. Baranova IB, Yaremenko Al, Zubareva AA, et al. Mucormycosis of the bones of the facial skull, nasal cavity and parana-sal sinuses in patients with COVID-19. Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23 (4): 347-58. DOI: 10.36488/стас.2021.4.347-358
3. Antonova IN, Grygoriants АР, Kalakutskiy NV, et al. Potential COVID-19 complications in oral cavity and maxillofacial area. Clinical Dentistry. 2022; 25 (2): 94-9. DOI: 10.37988/1811-153Х_2022_2_94
4. Zotkin EG. Heel preparations in the complex therapy of osteoarthritis. Pharmateka. 2016; s3-16: 30-4.
5. Zhevachevsky NG. The art of being healthy. Novosibirsk: RIF-Novosibirsk, 2021; 568 p.
| Attachment | Size |
|---|---|
| 2024_04_381-384.pdf | 1.67 MB |
Русский
English